Thermo Fisher Scientific Inc (NYSE:TMO) will begin trading ex-dividend on September 14, 2020. The quarterly dividend payment of $ 0.22 per share is scheduled to be paid on October 15, 2020. The dividend yield based on the latest trading day closing price was 0.21 %. Owners of shares, purchased before the ex-dividend date will be eligible for the dividend.
Dividends History
wpDataTable with provided ID not found!Click Here For More Historical Dividends Of Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc recently reported first quarter financial results on April 22, 2020, before market open, the Waltham based company recorded income for the first quarter of $ 2.94 per share, from the revenue of $ 6,230.00 million. The quarterly earnings hiked 4.63 percent while revenues boosted 1.71 percent compared with the same quarter last year.
The consensus estimates are income of $ 2.79 per share from $ 6173.81 million in revenue. The bottom line results beat street analysts by $ 0.15 or 5.38 percent, at the same time, top line results outshined analysts by $ 56.19 million or 0.91 percent.
Stock Performance
Shares of Thermo Fisher Scientific Inc traded up $ 1.41 or 0.34 percent on Thursday, reaching $ 419.73 with volume of 1.53 million shares. Thermo Fisher Scientific Inc has traded high as $ 429.34 and has cracked $ 417.91 on the downward trend
According to the previous trading day, closing price of $ 419.73, representing a 67.19 % increase from the 52 week low of $ 250.21 and a 5.35 % decrease over the 52 week high of $ 441.96.
The company has a market capital of $ 166.04 billion and is part of the Healthcare sector and Diagnostics & Research industry.
Thermo Fisher Scientific Inc. provides analytical and other instruments, laboratory equipment, software, consumables, reagents, instrument systems, chemicals, supplies, and services worldwide. Its Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery and production of new drugs and vaccines, and diagnosis of diseases to pharmaceutical, biotechnology, agricultural, clinical, academic, and government markets.
